Globus Medical
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 months.
- Its last 4 Sell calls were followed by a 13% average decline over the next quarter.
- Recent price momentum is -20.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 7.0% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation B+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 16.5x | Better than 54% |
| Forward P/E | 16.0x | Better than 52% |
| Price / Sales | 3.0x | Better than 41% |
| P/E vs own 5-yr range | 1st pctl | Better than 99% |
Growth A+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 42.2% | Better than 94% |
| Net income CAGR (3Y) | 41.4% | Better than 86% |
| Free cash flow CAGR (3Y) | 77.0% | Better than 90% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 67.4% | Better than 81% |
| Operating margin | 18.3% | Better than 73% |
| Net margin | 18.3% | Better than 77% |
| Return on equity | 12.3% | Better than 60% |
| Return on invested capital | 11.4% | Better than 73% |
Momentum C-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -23.0% | Better than 26% |
| 6-month return | -21.1% | Better than 26% |
| 12-month return (ex latest month) | -5.4% | Better than 27% |
| Distance below 52-week high | 34.0% | Better than 36% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.3x | Better than 82% |
| Debt to assets | 2.2% | Better than 87% |
| Interest coverage | -9.9x | Better than 13% |
| Free cash flow / net income | 107.7% | Better than 44% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 70.0% | Better than 48% |
| Upside to average target | 39.4% | Better than 59% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 68.60
- Open
- 68.44
- Day range
- 66.63 - 69.54
- Avg price
- 67.50
- Volume
- 1.51M
- Turnover
- 102.09M
- Turnover ratei
- 1.39%
- Volume ratioi
- 1.12
- Amplitudei
- 4.24%
- 52-week rangei
- 66.63 - 101.40
Valuation
- P/Ei
- 17.06
- P/E (TTM)i
- 16.48
- P/Bi
- 1.85
- EPSi
- 3.92
- Book value / shi
- 36.21
- Net profit
- 519.29M
- Net assets
- 4.80B
Share structure
- Market cap
- 8.86B
- Float capi
- 7.30B
- Shares out
- 132.47M
- Float sharesi
- 109.14M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
34.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-91.70M net over the window
Short interest
- Shares short
- 9.46M
- % of floati
- 7.04%
- Days to coveri
- 8.12
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Globus Medical (GMED)?
Globus Medical last traded at 66.89. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Globus Medical's market cap?
About 8.86B.
What is the P/E ratio of Globus Medical?
The trailing twelve-month P/E is 16.48, below its own 5-year average of 63.63 — toward the bottom of its historical range (0.72% percentile). See the Valuation tab for the full history.
Does Globus Medical pay a dividend?
Globus Medical does not currently pay a regular dividend.
Is Globus Medical a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 93.25, which implies 39.4% upside from the current price. This is not investment advice.
What is Globus Medical's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Globus Medical a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Globus Medical discussion 0 comments